| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8746068 | Journal of Clinical Tuberculosis and Other Mycobacterial Diseases | 2018 | 8 Pages | 
Abstract
												Tuberculosis (TB) is one of the leading causes of death worldwide, particularly in low- and middle-income countries. The global rates and numbers of drug resistant TB are rising. With increasing globalization, the spread of drug-resistant strains of TB has become a mounting global public health concern. We present a case of a young man previously treated for multi-drug resistant (MDR) TB in India who presented with neurological symptoms and central nervous system TB in the United States. His case highlights unique diagnostic and treatment challenges that are likely to become more commonplace with the increase of patients infected with drug-resistant TB and complicated extrapulmonary disease.
											Keywords
												FDAAFBXDR-TBMDR-TBDSTBALExtensively drug-resistant tuberculosisDrug susceptibility testingMRIAcid-fast bacillibedaquilineTuberculosisMagnetic resonance imagingcomputerized tomographyIntravenousDirectly observed therapyCNSWorld Health OrganizationFood and Drug AdministrationTuberculosis (TB)TuberculomaMultidrug-resistant tuberculosiscentral nervous systembronchoalveolar lavageleft upper lobeLULCSFCerebrospinal fluidDOTWHO
												Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Immunology and Microbiology (General)
												
											Authors
												Samantha R. Kaplan, Jeffrey Topal, Lynn Sosa, Maricar Malinis, Anita Huttner, Ajay Malhotra, Gerald Friedland, 
											